A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of cardiovascular disease.

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

(2012) TIIDM female patients (n = 215) with HbA1c = 7.0–10.5% and inadequate glycemic control on metformin (12 weeks ... Main action of SGLT2 inhibitors is the induction of glucosuria and ...

The clinic offers a patient assistance program for certain drugs; research has found that both SGLT2 inhibitors and GLP-1 agonists cost much more than metformin over a patient's lifetime.

SGLT-2 inhibitors, compared with DPP-4 inhibitors, were associated with a lower risk for liver cirrhosis among patients with type 2 diabetes. Sodium-glucose cotransporter 2 (SGLT-2) inhibitors ...

GLP-1 receptor agonists were more cardioprotective in younger people, but reduced HbA1c more with age. The age of type 2 ...

DPP-4 inhibitors are taken once a day, before or after meals. They’re generally well-tolerated and don’t cause hypoglycemia when taken alone or with metformin. (DPP-4 inhibitors also limit the ...

GLP-1RA and SGLT2 inhibitor combination therapy was associated with better cardiorenal outcomes than monotherapy among patients with type 2 diabetes. The cardiorenal benefits of sodium-glucose ...

SGLT2 inhibitors confer greater risk reductions ... Participants with metabolic syndrome who received 1,700 mg metformin daily with or without a Mediterranean diet intervention had reduced ...

Are you looking for effective medications to treat 'SGLT2 Inhibitors: An Evolution in Diabetes Mellitus?'? This page serves as your comprehensive resource hub, featuring the latest medications ...

The researchers found that both SGLT2 inhibitors and GLP-1 agonists were associated with a lower risk of major cardiovascular events, but the drug effects varied with the patients’ age.

The role of the kidney in blood glucose-level regulation was until recently underestimated. Renal gluconeogenesis, renal glucose uptake and tubular glucose reabsorption are the three ways of renal ...